Brainstorm Cell Therapeutics (NASDAQ:BCLI) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research report sent to investors on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Maxim Group downgraded shares of Brainstorm Cell Therapeutics from a buy rating to a hold rating in a report on Thursday, […]
More Stories
Sienna Resources (CVE:SIE) Trading 16.7% Higher – Time to Buy?
Sienna Resources Inc. (CVE:SIE – Get Free Report) shares rose 16.7% on Tuesday . The company traded as high as...
CION Investment Co. (NYSE:CION) to Issue $0.05 Annual Dividend
CION Investment Co. (NYSE:CION – Get Free Report) announced an annual dividend on Monday, December 23rd,NASDAQ Dividends reports. Shareholders of...
CION Investment Co. (NYSE:CION) to Issue $0.05 Annual Dividend
CION Investment Co. (NYSE:CION – Get Free Report) announced an annual dividend on Monday, December 23rd,NASDAQ Dividends reports. Shareholders of...
EOG Resources (EOG) – Analysts’ Weekly Ratings Updates
EOG Resources (NYSE: EOG) has recently received a number of price target changes and ratings updates: 12/20/2024 – EOG Resources...
EOG Resources (EOG) – Analysts’ Weekly Ratings Updates
EOG Resources (NYSE: EOG) has recently received a number of price target changes and ratings updates: 12/20/2024 – EOG Resources...
Head-To-Head Comparison: General Enterprise Ventures (GEVI) and Its Peers
Earnings & Valuation This table compares General Enterprise Ventures and its peers top-line revenue, earnings per share and valuation. Gross...